X-Chromosome Inactivation and Mutation Pattern in the Bruton’s Tyrosine Kinase Gene in Patients with X-linked Agammaglobulinemia

Molecular Medicine

Volumn 6, Issue 2, 2000, Pages 104-113

  Moschese, Viviana ^a,b,f   Orlandi, Paola ^a,b   Plebani, Alessandro ^c   Arvanitidis, Konstantinos ^d   Fiorini, Maurilia ^c   Speletas, Matthaios ^e   Mella, Patrizia ^c   Ritis, Kostas ^e   Sideras, Paschalis ^d   Finocchi, Andrea ^b   Livadiotti, Susanna ^b   Rossi, Paolo ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UMEÅ UNIVERSITY   (Sweden)

^e DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Agammaglobulinemia; Kinase Domain; Nonrandom Pattern; Random Pattern; RNase Cleavage Assay

Indexed keywords

AGAMMAGLOBULINAEMIA TYROSINE KINASE; COMPLEMENTARY DNA; PROTEIN TYROSINE KINASE; RIBONUCLEASE;

AGAMMAGLOBULINEMIA; ARTICLE; DNA SEQUENCE; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETIC LINKAGE; GENETICS; HUMAN; MALE; METABOLISM; MUTATION; POLYMERASE CHAIN REACTION; X CHROMOSOME;

AGAMMAGLOBULINEMIA; DNA, COMPLEMENTARY; DOSAGE COMPENSATION, GENETIC; FEMALE; HUMANS; LINKAGE (GENETICS); MALE; MUTATION; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE KINASES; RIBONUCLEASES; SEQUENCE ANALYSIS, DNA; X CHROMOSOME;

MLCS; MLOWN;

EID: 0034136824     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03401778     Document Type: Article

References (41)

1. P. Sideras C.I. Smith Molecular and cellular aspects of X-linked agammaglobulinemia Adv. Immunol. 1995 59 135 223 10.1016/S0065-2776(08)60631-8 1:CAS:528:DyaK2MXoslKks7w%3D 7484460
2. H.D. Ochs C.I. Smith X-linked agammaglobulinemia. A clinical and molecular analysis Medicine 1996 75 287 299 10.1097/00005792-199611000-00001 1:STN:280:DyaK2s7js1Oksg%3D%3D 8982147
3. S.-P. Kwan L. Kunkel G. Bruns R.J. Wedgwood S. Latt F.S. Rosen Mapping of the X-linked agammaglobulinemia locus by use of restriction fragment-length polymorphism J. Clin. Invest. 1986 77 649 52 10.1172/JCI112351 1:STN:280:DyaL287ht1Gmuw%3D%3D 3003164 423409
4. S. Guioli B. Arveiler B. Bardoni et al. Close linkage of probe p212 (Dxs178) to X-linked agammaglobulinemia Hum. Gen. 1989 84 12 21 10.1007/BF00210664
5. S. Tsukada D.C. Saffran D.J. Rawlings et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia Cell 1993 72 279 290 10.1016/0092-8674(93)90667-F 1:CAS:528:DyaK3sXkvFensro%3D 8425221
6. D. Vetrie I. Vorechovski P. Sideras et al. The gene ivolved in X-linked agammaglobulinemia is a member of the src family of protein tyrosine kinases Nature 1993 361 226 233 10.1038/361226a0 1:CAS:528:DyaK3sXitlajt7c%3D 8380905
7. P. Sideras S. Muller H. Shiels et al. Genomic organization of mouse and human Bruton’s agammaglobulinemia tyrosine kinase (BTK) loci J. Immunol. 1994 153 5607 5617 7989760 1:CAS:528:DyaK2MXis12ksbk%3D
8. M. Vihinen L. Nilsson C.I.E. Smith Tec homology (TH) adjacent to the PH domain FEBS Lett. 1994 350 263 265 10.1016/0014-5793(94)00783-7 1:CAS:528:DyaK2cXmslGitbg%3D 8070576
9. S. Desiderio Role of BTK in B cell development and signaling Curr. Opin. Immunol. 1997 9 534 540 10.1016/S0952-7915(97)80107-0 1:CAS:528:DyaK2sXlvVyqtLY%3D 9287186
10. A.B. Satterwaithe Z. Li O.N. Witte BTK function in B-cell development and response Semin. Immunol. 1998 10 309 316 10.1006/smim.1998.0123
11. qα on its effector Bruton’s tyrosine kinase Proc. Natl. Acad. Sci. U.S.A. 1998 95 12197 12201 10.1073/pnas.95.21.12197 1:CAS:528:DyaK1cXmsl2rsrk%3D 9770463 22808
12. K. Bence W. Ma T. Kozasa X.Y. Huang Direct stimulation of Bruton’s tyrosine kinase by G(q)-protein α subunit Nature 1997 389 296 299 10.1038/38520 1:CAS:528:DyaK2sXmtFGgu7s%3D 9305846
13. M. Hyvonen M. Saraste Structure of the PH domain and BTK motif from Bruton’s tyrosine kinase: molecular explanations for XLA EMBO J. 1997 16 3396 3404 10.1093/emboj/16.12.3396 1:CAS:528:DyaK2sXktlCjtrk%3D 9218782 1169965
14. B.K. Saha S.K. Curtis L.B. Vogler M. Vihinen Molecular and structural characterization of 5 novel mutations in the BTK gene from patients with XLA Mol. Med. 1997 3 477 485 10.1007/BF03401694 1:CAS:528:DyaK2sXlsVOktLg%3D 9260159 2230218
15. S. Bolland R.N. Pearse T. Kurosaki J.V. Ravatch SHIP modulates immune receptor responses by regulating membrane association of BTK Immunity 1999 8 509 516 10.1016/S1074-7613(00)80555-5
16. K. Salim M.J. Bottomley E. Querfurth et al. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton’s tyrosine kinase EMBO J. 1996 15 6241 6250 8947047 452447 1:CAS:528:DyaK28XnsFOhtbY%3D 10.1002/j.1460-2075.1996.tb01014.x
17. D.A. Fruman S.B. Snapper C.M. Yball et al. Impaired B-cell development and proliferation in absence of phosphoinositide 3-kinase p85 α Science 1999 283 393 397 10.1126/science.283.5400.393 1:CAS:528:DyaK1MXns1CisQ%3D%3D 9888855
18. H. Suzuki Y. Terauchi M. Fujiwara et al. Xid-like immunodeficiency in mice with disruption of the p85 a subunit of phosphoinositide 3-kinase Science 1999 283 390 392 10.1126/science.283.5400.390 1:CAS:528:DyaK1MXns1Cjug%3D%3D 9888854
19. WHO Scientific Group. Primary immunodeficiency diseases Clin. Exp. Immunol. 1995 99 suppl 1 1 24
20. H.M. Lederman J.A. Winkelstein X-linked agammaglobulinemia: an analysis of 96 patients Medicine 1985 64 145 156 10.1097/00005792-198505000-00001 1:STN:280:DyaL2M7oslCrtw%3D%3D 2581110
21. T. Hoffman R. Winchester M. Schulkind J.L. Frias E.M. Ayoub R.A. Good Hypoimmunoglobulinemia with normal T-cell function in female siblings Clin. Immunol. Immunopathol. 1977 7 364 371 10.1016/0090-1229(77)90070-8 1:STN:280:DyaE2s3gtlyltg%3D%3D 301456
22. M.E. Conley S.K. Sweinberg Females with a disorder phenotypically identical to XLA J. Clin. Immunol. 1992 12 139 143 10.1007/BF00918144 1:STN:280:DyaK383hvVKjsA%3D%3D 1560108
23. Y. Minegishi E. Coustan-Smith Y.-H. Wang M.D. Cooper D. Campana M.E. Conley Mutations in the human λ 5/14.1 gene result in B-cell deficiency and agammaglobulinemia J. Exp. Med. 1998 187 71 77 10.1084/jem.187.1.71 1:CAS:528:DyaK1cXjtV2ntA%3D%3D 9419212 2199185
24. L. Yel Y. Minegishi E. Coustan-Smith et al. Mutations in the mu heavy chain gene in patients with agammaglobulinemia N. Engl. J. Med. 1998 335 1486 1493 10.1056/NEJM199611143352003
25. Minegishi Y, Coustan-Smith E, Rapalus, (1999) An essential role for Iga in B-cell development. In: B lymphocyte biology and disease. Keystone Symposia. p. 76.
26. M.E. Conley P. Brown A.R. Pickard et al. Expression of the gene defect in X-linked agammaglobulinemia N. Engl. J. Med. 1986 315 564 567 10.1056/NEJM198608283150907 1:STN:280:DyaL283osV2isw%3D%3D 3488506
27. M.E. Conley J.M. Puck Carrier detection in typical and atypical XLA J. Pediatr. 1988 112 688 694 10.1016/S0022-3476(88)80683-8 1:STN:280:DyaL1c7pvFOlug%3D%3D 2896233
28. E.R. Fearon J.A. Winkelstein C.S. Livin D.M. Pardoll B. Vogelstein Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation N. Engl. J. Med. 1987 316 427 431 10.1056/NEJM198702193160802 1:STN:280:DyaL2s7hsFKrsQ%3D%3D 2880293
29. R.C. Allen R.C. Nachtman H.M. Rosenblatt J.W. Belmont Application of carrier testing to genetic counseling for X-linked agammaglobulinemia Am. J. Hum. Genet. 1994 54 25 35 7506482 1918059 1:STN:280:DyaK2c7gs1Gitw%3D%3D
30. M.M. Goldrich G.R. Kimball Q. Liu L.A. Martin S.S. Sommer J.-H. Tseng NIRCA: a rapid robust method for screening for unknown point mutations Biotechniques 1996 21 106 112
31. K. Ritis M. Speletas V. Tsironidou et al. Absence of BTK mutations in patients with acute myeloid leukemia Br. J. Hematol. 1998 102 1241 1248 10.1046/j.1365-2141.1998.00914.x 1:CAS:528:DyaK1cXmsVaru7o%3D
32. T. Hultman S. Stahl E. Homes M. Uhlen Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support Nucleic Acid Res. 1989 17 4937 4946 10.1093/nar/17.13.4937 1:CAS:528:DyaL1MXltFSgsrs%3D 2668874
33. E. Holinski-Feder M. Weiss O. Brandan et al. Mutation screening of the BTK gene in 56 families with XLA: 47 unique mutations without correlation to clinical course Pediatrics 1998 101 276 284 10.1542/peds.101.2.276 1:STN:280:DyaK1c7hvVemtQ%3D%3D 9445504
34. L.S. Wicker I. Scher X-linked immune deficiency (xid) of CBA/N mice Curr. Top. Microbiol. Immunol. 1986 124 87 101 3486747 1:STN:280:DyaL283hvFertg%3D%3D
35. I. Vorechovsky L. Luo J.M. Hertz et al. Mutation pattern in the BTK gene in 26 unrelated patients with XLA Hum. Mut. 1997 9 418 425 10.1002/(SICI)1098-1004(1997)9:5<418::AID-HUMU7>3.0.CO;2-# 1:CAS:528:DyaK2sXjtlKqt7w%3D 9143921
36. M. Vihinen S.P. Kwan T. Lesten et al. Mutations of the human BTK gene coding for BTK in X-linked agammaglobulinemia Hum. Mut. 1999 13 280 285 10.1002/(SICI)1098-1004(1999)13:4<280::AID-HUMU3>3.0.CO;2-L 1:CAS:528:DyaK1MXisFehsbo%3D 10220140
37. M. Vihinen et al. BTKbase: XLA mutation registry Immunol. Today 1996 17 502 506 10.1016/S0167-5699(96)80902-9 1:CAS:528:DyaK28XntVKku7o%3D 8961625
38. R.J. Benschop J.C. Cambier B-cell development: signal transduction by antigen receptors and their surrogates Curr. Op. Immunol. 1999 11 143 151 10.1016/S0952-7915(99)80025-9 1:CAS:528:DyaK1MXisFWksbk%3D
39. S. Nonoyama S. Tsukada T. Yamadori et al. Functional analysis of peripheral blood B-cells in patients with X-linked agammaglobulinemia J. Immunol. 1998 161 3925 3929 9780159 1:CAS:528:DyaK1cXmsFyrt7w%3D
40. M.J. Bykowski R.N. Haire Y. Ohta et al. Discordant phenotype in siblings with XLA Am. J. Hum. Genet. 1996 58 477 483
41. M.E. Conley D. Mathias J. Treadaway Y. Minegishi J. Rohrer Mutations in BTK in patients with presumed X-linked agammaglobulinemia Am. J. Hum. Genet. 1998 62 1034 1043 10.1086/301828 1:CAS:528:DyaK1cXlslCit7k%3D 9545398 1377085